Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids

Sponsor
University Hospital, Limoges (Other)
Overall Status
Completed
CT.gov ID
NCT00199576
Collaborator
(none)
670
15
13
44.7
3.4

Study Details

Study Description

Brief Summary

Tracheal intubation is a frequent procedure in intensive care units (ICU). Post-extubation laryngeal edema is a frequent complication with potential morbidity and mortality, and may lead to urgent tracheal re-intubation. Corticosteroids have been proposed to reduce the incidence of post-extubation laryngeal edema. A few clinical studies have been conducted in adult ICU patients and have led to discrepant results. These discrepancies may be related to the time lag separating the administration of the corticosteroids and the planned extubation. Accordingly, we tested the hypothesis that pretreatment with corticosteroids initiated 12 hours before a planned extubation may efficiently prevent the occurrence of postextubation laryngeal edema in critically-ill adults who have been mechanically ventilated for more than 36 hours in the ICU.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

We conducted a prospective, double-blind, placebo-controlled, multicenter trial of 12-hour-pretreatment by methylprednisolone before a planned extubation in adult patients ventilated for more than 36 hours in the ICU. Methylprednisolone (20 mg) or placebo was first administered intravenously 12 hours before extubation and continued every 4 hours until tube removal. Primary endpoint was the occurrence of laryngeal edema within 24 hours of extubation. Laryngeal edema was clinically diagnosed and considered as major when requiring tracheal reintubation.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids: a Prospective, Double-Blind, Placebo-Controlled Trial.
Study Start Date :
Dec 1, 2000
Study Completion Date :
Jan 1, 2002

Outcome Measures

Primary Outcome Measures

  1. Onset of a laryngeal edema within 24 hours after a planned tracheal extubation []

Secondary Outcome Measures

  1. - Severity of laryngeal edema (minor or major) []

  2. - Time to onset of edema (in minutes) after tracheal extubation []

  3. - Need for a tracheal re-intubation []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult ≥ 18 years

  • Intubated for ≥ 36 hours

  • Scheduled extubation

  • Informed written consent

Exclusion Criteria:
  • pregnancy

  • history of postextubation laryngeal dyspnea

  • laryngeal disease

  • tracheotomy

  • patient receiving corticotherapy prior to admission

  • traumatic intubation

  • participation to this study or to another trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 Réanimation médicale et chirurgicale - Hôpital d'Angoulême Angouleme France
2 Service de Réanimation - CH de Brive Brive France
3 Service de Réanimation - CH de Chartres Chartres France
4 Service de Réanimation - CH de Chateauroux Chateauroux France
5 Réanimation polyvalente - Hôpital de Cholet Cholet France
6 Service de Réanimation - CH de Dreux Dreux France
7 Service de Réanimation - CH de Le Mans Le Mans France
8 Service de Réanimation Polyvalente - Hôpital Dupuytren Limoges France 87042
9 Réanimation polyvalente - Hôpital d'Orléans Orleans France
10 Service Réanimation - CH de Poitiers Poitiers France
11 Service de Réanimation - CH Saint Malo Saint-Malo France
12 Service de Réanimation - CH de Saint Nazaire Saint-Nazaire France
13 Service de Réanimation - CH de Saintes Saintes France
14 Réanimation Médicale - Hôpital Bretonneau Tours France
15 Service de Réanimation - CH de Vannes Vannes France

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

  • Study Chair: Eric Bellissant, MD, PhD, CHU Rennes
  • Principal Investigator: Bruno Francois, MD, CH Limoges

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00199576
Other Study ID Numbers:
  • AFSSAPS 001533
  • CIC0203/023
First Posted:
Sep 20, 2005
Last Update Posted:
Sep 20, 2005
Last Verified:
Sep 1, 2005

Study Results

No Results Posted as of Sep 20, 2005